Urethral bulking with Bulkamid: An analysis of efficacy, safety profile, and predictors of functional outcomes in a single-center cohort.
Bulkamid
elderly
female
mixed incontinence
stress urinary incontinence
urethral bulking
urinary incontinence
Journal
Neurourology and urodynamics
ISSN: 1520-6777
Titre abrégé: Neurourol Urodyn
Pays: United States
ID NLM: 8303326
Informations de publication
Date de publication:
06 2020
06 2020
Historique:
received:
19
03
2020
accepted:
04
05
2020
pubmed:
15
5
2020
medline:
18
12
2020
entrez:
15
5
2020
Statut:
ppublish
Résumé
The aim of the present work is to analyze the safety profile, effectiveness, and favorable and unfavorable predictors of clinical outcome in urethral bulking with Bulkamid, and to better identify the ideal candidate for the procedure. We included all consecutive female patients treated with urethral bulking with Bulkamid at our institution within 2 years. Patients were affected by stress urinary incontinence (SUI) or mixed incontinence. Incontinence severity was classified as "mild" (urinary leakage <50 g/die), "moderate" (50-200 g/die), or "severe" (>200 g/die) at 24-hours pad test. Clinical success was defined as "dry" (no pads); clinical failure included "partial improvement" (>50% 24-hours pad test reduction) and "no benefit" (<50% 24-hours pad test reduction). The χ The success rate was 36.1% (n = 35). Forty-three patients (44.3%) reported continence improvement. Complications included eight urinary retention cases (8.2%). Statistically significant correlation was observed between incontinence severity and clinical outcome in thee χ Bulkamid procedure could be proposed with good results in elderly patients or in patients requiring a low-invasive procedure with low risk of complications, affected either by SUI or mixed incontinence and with mild to moderate incontinence. Previous training to clean intermittent self-catheterization maneuver should be performed.
Substances chimiques
Acrylic Resins
0
Bulkamid
0
Hydrogels
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1523-1528Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Kirchin V, Page T, Keegan PE, et al. Urethral injection therapy for urinary incontinence in women. Cochrane Database Syst Rev. 2017;7:CD003881.
Maher CF, O'Reilly BA, Dwyer PL, Carey MP, Cornish A, Schluter P. Pubovaginal sling versus transurethral Macroplastique for stress urinary incontinence and intrinsic sphincter deficiency: a prospective randomised controlled trial. Int J Obstet Gynaecol. 2005;112:797-801.
Ghoniem GM, Miller CJ. A systematic review and meta-analysis of Macroplastique for treating female stress urinary incontinence. Int Urogynecol J Pelvic Floor Dysfunct. 2013;24:27-36.
Pai A, Al-Singary W. Durability, safety and efficacy of polyacrylamide hydrogel (Bulkamid®) in the management of stress and mixed urinary incontinence: three year follow up outcomes. Cent Eur J Urol. 2015;68:428-433.
Leone Roberti Maggiore U, Bogani G, Meschia M, et al. Urethral bulking agents versus other surgical procedures for the treatment of female stress urinary incontinence: a systematic review and meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2015;189:48-54.
Ford AA, Rogerson L, Cody JD, Aluko P, Ogah JA. Mid-urethral sling operations for stress urinary incontinence in women. Cochrane Database Syst Rev. 2017;7:CD006375.
Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR), The safety of surgical meshes used in urogynecological surgery, 3 December 2015.
U. S. Food and Drug Administration (FDA). Considerations about Surgical Mesh for SUI. 2019. https://www.fda.gov/medical-devices/urogynecologic-surgical-mesh-implants/considerations-about-surgical-mesh-sui. Accessed 17 March 2020.
Casteleijn FM, Zwolsman SE, Kowalik CR, Roovers JPWR. Patients' perspectives on urethral bulk injection therapy and mid-urethral sling surgery for stress urinary incontinence. Int Urogynecol J. 2018;29:1249-1257.
Robinson D, Anders K, Cardozo L, et al. What women want-their interpretation of the concept of cure. Neurourol Urodyn. 2002;21:429-430.
Burkhard FC, Bosch JLHR, Cruz F, et al. EAU guidelines on urinary incontinence. https://uroweb.org/guideline/urinary-incontinence/. Accessed 17 March 2020.
Serati M, Soligo M, Braga A, et al. Efficacy and safety of polydimethylsiloxane injection (Macroplastique®) for the treatment of female stress urinary incontinence: results of a series of 85 patients with ≥3 years of follow-up. BJU Int. 2019;123:353-359.
Shek KL, Dietz HP. The urethral motion profile: a novel method to evaluate urethral support and mobility. Aust New Zeal J Obstet Gynaecol. 2008;48:337-342.
Dalpiaz O, Curti P. Role of perineal ultrasound in the evaluation of urinary stress incontinence and pelvic organ prolapse: a systematic review. Neurourol Urodyn. 2006;25:301-306.
Robinson BL, Geller EJ, Parnell BA, et al. Diagnostic accuracy of visual urethral mobility exam versus Q-Tip test: a randomized crossover trial. Am J Obstet Gynecol. 2012;206:528.e1-528.e6.
Chen GD, Su TH, Lin LY. Applicability of perineal sonography in anatomical evaluation of bladder neck in women with and without genuine stress incontinence. J Clin Ultrasound. 1997;25:189-194.
Abrams P, Cardozo L, Fall M, et al. The standardisation of terminology in lower urinary tract function: report from the standardisation sub-committee of the International Continence Society. Urology. 2003;61:37-49.
Li B, Zhu L, Xu T, Lang J. The optimal threshold values for the severity of urinary incontinence based on the 1-hour pad test. Int J Gynecol Obstet. 2012;118:117-119.
Soroka D, Drutz HP, Glazener CMA, Hay-Smith EJC, Ross S. Perineal pad test in evaluating outcomes of treatments for female incontinence: a systematic review. Int Urogynecol J. 2002;13:165-175.
Yalcin I, Bump RC. Validation of two global impression questionnaires for incontinence. Am J Obstet Gynecol. 2003;189:98-101.
Zullo MA, Plotti F, Bellati F, Muzii L, Angioli R, Panici PB. Transurethral polydimethylsiloxane implantation: a valid option for the treatment of stress urinary incontinence due to intrinsic sphincter deficiency without urethral hypermobility. J Urol. 2005;173:898-902.